科研
教育
登录
CN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
State Key Laboratory of Bioactive Substance and Function of Natural Medicines,
Institute of Materia Medica,
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica
Xingkai Wang has not added Biography.
If you are Xingkai Wang and would like to personalize this page please email our Author Liaison for assistance.
A benzoxazole compound as a novel MEK inhibitor for the treatment of RAS/RAF mutant cancer.
International journal of cancer Jul, 2019 | Pubmed ID: 30628057
Chinese Academy of Medical Sciences and Peking Union Medical College
Lulu Zhang*,1,
Siqi Zhang*,2,
Wenyu Wu1,
Xingkai Wang2,
Jieting Shen2,
Dongyuan Wang4,
Kuan Hu*,2,3,
Ming-Rong Zhang*,3,
Feng Wang*,1,
Rui Wang*,2
1Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University,
2State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College,
3Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology,
4Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
政策
使用条款
隐私
联系我们
向图书馆推荐
JoVE 新闻简报
JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
发表
图书馆员
访问权限
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。